<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03417063</url>
  </required_header>
  <id_info>
    <org_study_id>D171100003017003</org_study_id>
    <nct_id>NCT03417063</nct_id>
  </id_info>
  <brief_title>Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression</brief_title>
  <official_title>Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression (ICASMAP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tsinghua University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>309th Hospital of Chinese People's Liberation Army</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Navy General Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospitals affiliated to the China PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Huairou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Pinggu District Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Shuyi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin First Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin 4th Centre Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Union Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Chengde Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tangshan Gongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Hebei North University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cangzhou People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harrison International Peace Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tsinghua University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke has become the leading cause of death in China. It has been shown that intracranial
      artery stenosis (ICAS) plays a key role in Chinese stroke patients. Although most of stenotic
      diseases in intracranial arteries are atherosclerotic, a substantial number of other vascular
      diseases, such as dissection, arteritis, moyamoya disease, and reversible cerebral
      vasoconstriction syndrome (RCVS), can also lead to intracranial artery luminal narrowing. It
      is challenging to differentiate the etiologies of ICAS relying on measuring luminal narrowing
      by angiographical approaches. In addition, the progression of intracranial atherosclerotic
      disease (ICAD) has been demonstrated to be highly associated with the risk of ischemic
      cerebrovascular events. However, the influence factors for ICAD progression remains unclear.

      High-resolution magnetic resonance imaging (HR-MRI) has been widely used to assess ICAS
      diseases. The different etiologies of ICAS are differentiable by MR-MRI according to the
      features of location, shape, signal pattern, remodeling, and contrast enhancement.
      Investigators have proved that HR-MRI is a reproducible technique that may be reliably
      utilized to monitor the changes of ICAD during natural follow-up or medical treatment.

      The ICASMAP (Intracranial Artery Stenosis MR Imaging: Aetiology and Progression) is a
      prospective, cross-sectional, observational, and multicenter study. The objectives of ICASMAP
      are to determine: 1) the spectrum of etiology of ICAS in stroke patients; and 2) the
      influence factors for progression of ICAD. A total of 300 patients with symptomatic stenotic
      disease in intracranial arteries (stenosis range: 30%-99%) will be recruited within two weeks
      after symptom onset from 18 different hospitals across Beijing-Tianjin-Hebei region in China
      within 1 year. All the patients will undergo HR-MRI for intracranial arteries at baseline,
      one-year, and two-years. The clinical risk factors will be collected and blood draw will be
      conducted. The ICASMAP study may help to improve the precise diagnosis and intervention of
      ICAS and stroke prevention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2017</start_date>
  <completion_date type="Anticipated">March 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Progression of plaque burden</measure>
    <time_frame>24 months</time_frame>
    <description>Maximum wall thickness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression of luminal stenosis</measure>
    <time_frame>24 months</time_frame>
    <description>Mild (&lt;50%), moderate (50-70%), severe (70-99%), and occlusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of plaque components</measure>
    <time_frame>24 months</time_frame>
    <description>Presence of intraplaque hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebrovascular events</measure>
    <time_frame>24 months</time_frame>
    <description>ischemic stroke or transient ischemia attack</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <condition>Intracranial Artery Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In this study, we plan to recruit patients with recent transient ischemic attack or
        ischemic stoke within two weeks after symptom onset and intracranial artery stenosis
        (30%-99%) at least in intracranial internal carotid artery,basilar artery, M1 segment of
        middle cerebral artery, A1 segment of anterior cerebral artery, or P1 segment of posterior
        cerebral artery determined by computed tomography angiography or magnetic resonance
        angiography. The patients will be recruited from 18 hospitals in Beijing-Tianjin-Hebei area
        of China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with recent transient ischemic attack or ischemic stoke within two weeks
             after symptom onset and intracranial artery stenosis (30%-99%) at least in
             intracranial internal carotid artery,basilar artery, M1 segment of middle cerebral
             artery , A1 segment of anterior cerebral artery, or P1 segment of posterior cerebral
             artery determined by computed tomography angiography or magnetic resonance (MR)
             angiography.

        Exclusion Criteria:

          -  Patients with specific carotid artery atherosclerotic plaques

          -  Patients with evidence of may causing cardiac thrombosis disease

          -  Patients with claustrophobia

          -  Patients with contraindications to MR imaging

          -  Patients with heart or respiratory failure

          -  Patients with renal insufficiency (serum creatinine &gt;133umol/L)

          -  Patients with serious disturbance of consciousness

          -  Patients with brain tumors

          -  Patients with cerebral hemorrhage

          -  Pregnant woman or plan to pregnant within recent 2 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xihai Zhao, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tsinghua University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongye Li, MD</last_name>
    <phone>1561153321</phone>
    <email>dongyeli1988@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yongjun Han, MD</last_name>
    <phone>15116962341</phone>
    <email>lalyn0322@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University</name>
      <address>
        <city>Beijing</city>
        <zip>100084</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Le He, MD</last_name>
      <phone>861062796175</phone>
      <email>hele0806@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Xihai Zhao, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke. 2014 Mar;45(3):663-9. doi: 10.1161/STROKEAHA.113.003508. Epub 2014 Jan 30.</citation>
    <PMID>24481975</PMID>
  </reference>
  <reference>
    <citation>Ahn SH, Lee J, Kim YJ, Kwon SU, Lee D, Jung SC, Kang DW, Kim JS. Isolated MCA disease in patients without significant atherosclerotic risk factors: a high-resolution magnetic resonance imaging study. Stroke. 2015 Mar;46(3):697-703. doi: 10.1161/STROKEAHA.114.008181. Epub 2015 Jan 27. Erratum in: Stroke. 2015 Sep;46(9):e222.</citation>
    <PMID>25628303</PMID>
  </reference>
  <reference>
    <citation>Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, Sacco RL, Connolly SJ; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014 Apr;13(4):429-38. doi: 10.1016/S1474-4422(13)70310-7.</citation>
    <PMID>24646875</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, Wang A, Meng X, Li H, Wang Y. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke. 2013 May;44(5):1232-7. doi: 10.1161/STROKEAHA.111.000302. Epub 2013 Feb 26.</citation>
    <PMID>23444308</PMID>
  </reference>
  <reference>
    <citation>Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008 Aug;39(8):2396-9. doi: 10.1161/STROKEAHA.107.505776. Epub 2008 Jun 5. Review.</citation>
    <PMID>18535283</PMID>
  </reference>
  <reference>
    <citation>Choi YJ, Jung SC, Lee DH. Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries. J Stroke. 2015 Sep;17(3):238-55. doi: 10.5853/jos.2015.17.3.238. Epub 2015 Sep 30. Review.</citation>
    <PMID>26437991</PMID>
  </reference>
  <reference>
    <citation>Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, Tirschwell DT, Hatsukami T, Anzai Y, Yuan C. Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes. Stroke. 2015 Jun;46(6):1567-73. doi: 10.1161/STROKEAHA.115.009037. Epub 2015 May 7.</citation>
    <PMID>25953365</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tsinghua University</investigator_affiliation>
    <investigator_full_name>Xihai Zhao</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Intracranial artery</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Intracranial artery stenosis</keyword>
  <keyword>High-Resolution Magnetic Resonance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

